VIRTUAL SURGERY SIMULATION TRAINING BUSINESS PLAN

I. Executive Summary

Company Description

SurgiSim Labs (name combining surgical practice and simulation laboratory) is a medical technology company founded for a 2026 U.S. launch and headquartered in Boston, MA. We operate in the surgical education and medical simulation sector as a B2B SaaS provider serving hospitals, academic medical centers, and medical device companies. Our core product is an immersive virtual reality training platform that functions as a "flight simulator" for the operating room, pairing high-fidelity VR scenarios with procedure-specific analytics and optional haptic integrations. One-liner: We deliver repeatable, measurable surgical practice in a simulated OR environment.

We develop and license software, curate scenario libraries, integrate device-specific modules, and provide data dashboards and training curricula to customers. What sets us apart is our combination of clinician-designed scenarios, engineering-grade simulation fidelity, and built-in proficiency metrics that map directly to credentialing needs. Our initial target market is US teaching hospitals and device OEMs; short-term goals are pilot deployments at six academic centers and an early revenue run-rate by Q4 2026. Long-term goals are national adoption as a credentialing standard, regulatory-aligned performance metrics, and enterprise partnerships with medical schools and device manufacturers. One-liner: Our aim is to set the gold standard for data-driven surgical proficiency and patient safety.

Problem

Traditional surgical training relies on cadavers and animal labs that are expensive, scarce, and non-repeatable, leaving residents with limited hands-on practice for rare or complex procedures. Training access is uneven because operating room schedules and faculty availability restrict practice time across programs.

Assessment is largely subjective and episodic, so programs lack 24/7 objective metrics to track competency and improvement. This raises costs per trainee, reduces safe repetition opportunities, increases variability in trainee experience, and limits faculty time for supervised practice.

Residents need scalable, anytime simulation with objective metrics to shorten the learning curve and improve outcomes.

Solution

Traditional surgical training is costly, logistically heavy, and lacks repeatable, objective measures of readiness, which prolongs the learning curve and raises patient-safety risk. Our state-of-the-art virtual reality platform delivers a comprehensive library of hyper-realistic surgical simulations with advanced haptic feedback and integrated data analytics that provide real-time performance tracking and proficiency scoring for hospitals and universities.

Residents rehearse high-risk cases without patient exposure; faculty get objective performance data; institutions scale curricula across sites — realistic practice, measurable proficiency, institutional-ready deployment.

Mission Statement

We create the most realistic, data-driven virtual training environment to accelerate the surgical learning curve, reduce healthcare costs, and improve patient outcomes. We equip surgeons with immersive tools for measurable skill mastery and continuous assessment. By 2026 we will be the indispensable partner for every surgical residency program in the United States.

Key Success Factors

Success rests on clinical credibility, proprietary tech, predictable economics, and a team that can execute.

• Proprietary haptic feedback technology coupled with a library of validated surgical modules.
• Strong academic medical center partnerships ensuring highest clinical standards.
• B2B SaaS revenue model delivering recurring revenue and high gross margins.
• Experienced management team including a CEO/Medical Director and Lead VR Engineer.
• Rapid market entry with a 5‑month payback enabling quick customer ROI and fast scaling.

Financial Summary

Financial snapshot for the Executive Summary of the Virtual Surgery Simulation Training business plan.

Financial requirements: minimum cash reserve $797,000 (required Feb-26). The project reaches breakeven in Feb-26 (2 months post-launch) and achieves payback in 5 months. Expected overall returns: IRR 42.2% and ROE 45.76%.

Financials show rapid breakeven, fast payback, and strong scalable profitability.

Funding Requirements

The company requires a minimum cash balance of $797,000 to reach breakeven by Feb-26 and fund initial capital, marketing, and early operating losses.

Projected first-year revenue is $4,331,000, scaling to $22,545,000 by 2030; EBITDA rises from $1,919,000 to $17,688,000, with breakeven in 2 months, a 5-month payback, IRR 42.2%, and ROE 45.76%.